FMP

FMP

Enter

PCRX - Pacira BioSciences, ...

Valuation of Pacira BioSciences, Inc.(PCRX), Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for h

photo-url-https://financialmodelingprep.com/image-stock/PCRX.png

Pacira BioSciences, Inc.

PCRX

NASDAQ

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

26.1 USD

-0.67 (-2.57%)

Valuation Date:

Apr 18, 2024 4:00 PM

Share Price on Valuation Date

$26.1

Stock Beta

0.753

Shares Outstanding

46500800

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep